ZVSA logo

ZyVersa Therapeutics (ZVSA) Free Cash Flow

Annual FCF

-$8.72 M
-$7.23 M-483.49%

December 1, 2023


Summary


Performance

ZVSA Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherZVSAcash flowmetrics:

Quarterly FCF

-$644.40 K
+$1.27 M+66.33%

September 1, 2024


Summary


Performance

ZVSA Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherZVSAcash flowmetrics:

TTM FCF

-$9.12 M
+$292.00 K+3.10%

September 1, 2024


Summary


Performance

ZVSA TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherZVSAcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

ZVSA Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-483.5%+82.9%-15.4%
3 y3 years-70.7%-104.3%-1223.1%
5 y5 years-70.7%-104.3%-1223.1%

ZVSA Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-483.5%at low-104.3%+86.0%-2339.2%+3.1%
5 y5-year-483.5%at low-104.3%+86.0%-2339.2%+3.1%
alltimeall time-483.5%at low-104.3%+86.0%-2339.2%+3.1%

ZyVersa Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$644.40 K(-66.3%)
-$9.12 M(-3.1%)
Jun 2024
-
-$1.91 M(-49.3%)
-$9.41 M(+19.1%)
Mar 2024
-
-$3.78 M(+35.5%)
-$7.91 M(-9.3%)
Dec 2023
-$8.72 M
-$2.79 M(+197.7%)
-$8.72 M(+37.3%)
Sep 2023
-
-$936.40 K(+129.7%)
-$6.35 M(+9.4%)
Jun 2023
-
-$407.60 K(-91.1%)
-$5.80 M(+1.6%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$4.59 M(+1002.5%)
-$5.71 M(+282.0%)
Dec 2022
-$1.49 M(-70.6%)
-$416.30 K(+7.0%)
-$1.49 M(+38.6%)
Sep 2022
-
-$388.90 K(+23.3%)
-$1.08 M(+56.4%)
Jun 2022
-
-$315.50 K(-15.6%)
-$689.50 K(+84.4%)
Mar 2022
-
-$374.00 K
-$374.00 K
Dec 2021
-$5.08 M(-0.7%)
-
-
Dec 2020
-$5.11 M
-
-

FAQ

  • What is ZyVersa Therapeutics annual free cash flow?
  • What is the all time high annual FCF for ZyVersa Therapeutics?
  • What is ZyVersa Therapeutics annual FCF year-on-year change?
  • What is ZyVersa Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for ZyVersa Therapeutics?
  • What is ZyVersa Therapeutics quarterly FCF year-on-year change?
  • What is ZyVersa Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for ZyVersa Therapeutics?
  • What is ZyVersa Therapeutics TTM FCF year-on-year change?

What is ZyVersa Therapeutics annual free cash flow?

The current annual FCF of ZVSA is -$8.72 M

What is the all time high annual FCF for ZyVersa Therapeutics?

ZyVersa Therapeutics all-time high annual free cash flow is -$1.49 M

What is ZyVersa Therapeutics annual FCF year-on-year change?

Over the past year, ZVSA annual free cash flow has changed by -$7.23 M (-483.49%)

What is ZyVersa Therapeutics quarterly free cash flow?

The current quarterly FCF of ZVSA is -$644.40 K

What is the all time high quarterly FCF for ZyVersa Therapeutics?

ZyVersa Therapeutics all-time high quarterly free cash flow is -$315.50 K

What is ZyVersa Therapeutics quarterly FCF year-on-year change?

Over the past year, ZVSA quarterly free cash flow has changed by +$3.13 M (+82.94%)

What is ZyVersa Therapeutics TTM free cash flow?

The current TTM FCF of ZVSA is -$9.12 M

What is the all time high TTM FCF for ZyVersa Therapeutics?

ZyVersa Therapeutics all-time high TTM free cash flow is -$374.00 K

What is ZyVersa Therapeutics TTM FCF year-on-year change?

Over the past year, ZVSA TTM free cash flow has changed by -$1.21 M (-15.36%)